|
Geographic Management of Cancer Health Disparities Program (GMaP) Region 1-South
November 18, 2022 Newsletter
|
|
|
GMaP is an integrated network of three regions within the United States. The GMaP R1S hub is based at the UNC Lineberger Comprehensive Cancer Center and in partnership with the Hollings Cancer Center and Vanderbilt-Ingram Cancer Center, serves North Carolina, South Carolina and Tennessee.
|
|
|
You are receiving this newsletter as a Cancer Researcher in GMaP Region 1-South.
|
|
|
|
GMaP Region 1-South
Happy November!
|
|
TEAM to Pilot Test Use of Training Champions at Minority-Serving Institutions
The Center to Reduce Cancer Health Disparities is excited to announce the issuance of a funding opportunity to solicit applications for the Transformative Educational Advancement and Mentoring Network (TEAM). We encourage you to share this opportunity with your grantees and networks.
| TEAM’s purpose is to pilot test the use of Training Champions (TCs) at Minority-Serving Institutions (MSIs) to provide education and career development navigation for diverse scholars. The program is designed to develop the skills and competencies for predoctoral, postdoctoral, and/or Early Stage Investigators to successfully compete for independent grant funding. |
|
 |
Applications should be designed to provide scholars with the educational resources and tools needed to navigate the NIH funding process, from identifying appropriate grant mechanisms through the application process and beyond. Principal Investigators and MSI support faculty will also be expected to adapt or leverage culturally tailored educational activities, short courses, and resources that enhance subject matter expertise and professional career development. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:
- Courses for Skills Development: Applicants should describe in detail the courses and training resources for skills development that will be integrated within institutions. Applicants should also highlight how this program will integrate with and enhance the institution's existing resources and expertise in cancer and cancer health disparities research, grantsmanship, and scholars’ professional career development.
- Mentoring Activities: Researchers from diverse backgrounds, including those from underrepresented groups, are encouraged to participate as mentors in the TEAM program. Mentors should have advanced degrees, multifaceted research expertise, and experience in cancer and cancer health disparities, scientific writing, grantsmanship, and other topics relevant to the applicant’s proposal.
Key Dates
- Pre-Application Webinar: December 1, 2022
- Letter of Intent Due Date: January 10, 2023
- Application Due Date: February 10, 2023
- Earliest Start Date: December 2023
Pre-Application Webinar
Prospective applicants are encouraged to attend the TEAM Pre-Application Webinar, which will take place on December 1, 2022 from 11:00 am-12:00 pm Eastern. Program staff will share helpful information and guidance, and attendees will have the opportunity to pose questions.
Register today to join us. |
|
|
APPLICATIONS DUE BY FEBRUARY 17, 2023: Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment Funding Opportunity Announcements
The National Cancer Institute, the National Institute on Drug Abuse, and the National Center for Complementary and Integrative Health invite Cooperative Agreement applications to two new companion Requests for Applications (RFAs) for prospective research studies to assess the benefits and harms of cannabis and cannabinoid use among adult cancer patients during active treatment and for a coordinating center to facilitate research activities:
Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01, Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-052.html
Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24, Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-053.html
Letters of intent are due January 18, 2023, and the application receipt date for both FOAs is February 17, 2023.
There will be a pre-application webinar on October 26, 2022, from 3:30 – 4:30 p.m. ET. The webinar will include an overview of the two RFAs as well as specific requirements for applications submitted in response to the RFAs. The webinar will conclude with an open question and answer session. To register for the webinar, visit https://cbiit.webex.com/cbiit/j.php?RGID=r5f0736838c39202eff1d48ab012ec956. Potential applicants are encouraged to submit their questions in advance to nciepicommunications@mail.nih.gov or via registration. A few weeks after the webinar, a recording will be available on https://epi.grants.cancer.gov/cannabis.
|
|
|
University of Pittsburgh School of Public Health UPMC Hillman Cancer Center
Postdoctoral Scholarship Position in the Exposomics and Cancer Epidemiology is Available
Sponsored by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), this program focuses on a multi-disciplinary training experience in cancer control and population sciences. The postdoctoral fellowship includes integrated training in cancer etiology and preventive research within a large Cancer Center and School of Public Health at the University of Pittsburgh. The standard postdoctoral fellowship duration is two years, and accepted fellows will be provided with a generous stipend, research budget, travel allowance, and healthcare benefits according to the current NIH guidelines. In addition, fellows will be provided with tuition and fees for pursuing a master-level graduate degree at the University of Pittsburgh School of Public Health if desired. This position is renewable after two years depending on the candidate’s performance and funding situation.
This position will work with Dr. Peng Gao from the Department of Environmental and Occupational Health and Dr. Jian-Min Yuan from UPMC Hillman Cancer Center and the Department of Epidemiology on applying the chemical exposomics approach in the discovery and validation of novel risk/protective factors for lung and other cancer types within longitudinal prospective cohort studies. University of Pittsburgh School of Public Health and UPMC Hillman Cancer Center also include multiple disciplinary mentoring teams conducting research from mechanistic experiments and observational studies in populations to randomized intervention studies and testing the efficacy of chemo- and immuno- preventive agents on cancer protection in humans.
The candidate is expected to be familiar with the computational part of -omics (exposomics, metabolomics, and/or proteomics) approaches using high-resolution mass spectrometry. Prior training and experience in non-targeted analysis methods and the use of R or Python are required. Previous experience in the experimental part of using LC/GC-HRMS and targeted analyses are not required but highly desired.
The potential fellow must be a U.S. citizen or permanent resident due to the restriction of the funding mechanism by NIH. A candidate who recently earned a PhD in analytical chemistry, environmental health, bioinformatics, cheminformatics, or other related fields and is interested in cross-disciplinary training and research experience in cancer etiology, prevention, and control is encouraged to apply. Candidates from underrepresented populations are strongly encouraged to apply for this position and will be given the preferences. Please send a cover letter, a most updated CV, and the contact information of references to Dr. Peng Gao, PhD at peg47@pitt.edu and Dr. Jain-Min Yuan, MD, PhD at yuanj@upmc.edu.
|
|
|
Post Doctoral Opportunity at Mayo Clinic AZ!
Recruiting several Postdoctoral Research Fellow in the Department of Quantitative Health Science within the Division of Epidemiology at Mayo Clinic College of Medicine and Sciences. Fellow will be mentored by Dr. Ewan K. Cobran. Ideal candidates would have research interests in the areas of prostate cancer health disparities, community-based participatory research, health equity, pharmacoepidemiology, cancer health services research, or closely related area. Experience with population-level datasets (Medicare, administrative claims, Health and SEER-Medicare) and community-based participatory research preferred.
Full Description
The post-doctoral fellow will collaborate on funded research projects and be encouraged to develop an independent research portfolio. Approximately half of your time will be dedicated to developing an independent research agenda in the area of prostate cancer disparities, cancer health services, outcomes, and community-based participatory research and the other half dedicated to active NIH-funded projects. In addition to collaborations with Dr. Cobran, you will have opportunities to collaborate with faculty in the Division of Epidemiology at and the broader Mayo Clinic research community. You may also take advantage of training opportunities related to grant writing and professional development at Mayo Clinic.
Application Details
Please email your CV, research statement, and writing sample to Dr. Ewan K. Cobran ( cobran.ewan@mayo.edu).
Contact
Ewan K. Cobran, Ph.D.
Email: cobran.ewan@mayo.edu
Telephone: (480) 301-6392
Position Detail
|
|
|
|
The Division of Intramural Research of the National Institute of Neurological Disorders and Stroke, NIH is searchingfor Intramural Research Training Award (IRTA) Postdoctoral Trainee in the Surgical Neurology Branch,
Developmental Therapeutics and Pharmacology (DTAP). Dr. Sadhana Jackson’s laboratory combines CNS
pharmacokinetic evaluations and cell biological approaches to understand the interplay between the blood-brain
barrier (BBB) permeability and brain tumor cell proliferation. We use a combination of cell biology, molecular
biology, imaging, pharmacokinetics and animal tumor models. It is expected that as a member of this lab, one will
have an opportunity to be exposed to all these areas.
We value a vibrant and collaborative environment where lab members share ideas, reagents and expertise and
desire to work on fundamental problems focused on targeted agents that affect the highly restricted BBB and
malignant brain tumor cells. Our work uses an integrated bench-to-bedside approach that aims to 1) study the
efficacy of targeted tumor and BBB directed therapy, 2) define the mechanisms that drive differences in
neuropharmacokinetics of agents to the CNS, and 3) evaluate exquisite parameters via neuro-imaging of CNS
permeability amongst malignant brain tumors. Our overall goal is to enhance our understanding of the
heterogeneity of blood-brain barrier permeability among tumor cells and develop mechanism-based therapeutic
interventions to treat affected brain tumor patients at the NIH Clinical Center.
To apply:
The application should include:
(1) Cover letter with a brief description of candidate's interest in the position, research experience and
long-term career goals
(2) Curriculum Vitae
(3) Representative publications
(4) Contact information of three references
Please email all materials as one PDF file to Dr. Jackson (sadhana.jackson@nih.gov)
Investigator, National Institute of Neurological Disorders and Stroke, SNB, DTAP, Building 10, Room 7D45,
10 Center Drive, MSC 1414, Bethesda, MD 20892.
Review of applications will begin immediately and will continue until the position is filled.
The NIH is dedicated to equity, diversity and inclusion in its training and employment programs
|
|
|
Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional). The purpose of the Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control) Funding Opportunity Announcement (FOA) is to build implementation science centers in low- and middle-income countries (LMICs). This initiative will support implementation science research capacity-building activities, including research projects that identify, develop, and test innovative theory-based strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based cancer control interventions in LMICs. Application due date: November 8, 2022.View the CGH list of funding for global cancer research and training.
|
|
New Post Doctoral Fellowship Opportunities!
|
|
We are excited to let you know that NHLBI has released two companion FOAs with the entitled of “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-015.html and “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-016.html along with the notice of availability of Frequently Asked Questions (FAQs) (https://grants.nih.gov/grants/guide/notice-files/NOT-HL-22-027.html).
|
|
Data and Technology Advancement (DATA) National Service Scholar Program: Data Scientists Advancing Biomedical Research
The National Institutes of Health (NIH) Office of Data Science Strategy (ODSS) Data and Technology Advancement (DATA) National Service Scholar Program is seeking experienced data and computer scientists and engineers to tackle challenging biomedical data problems with the potential for substantial public health impact.
Today, biomedical datasets are measured in petabytes and comprise data types ranging from DNA sequences to wearable sensor-generated outputs like heart rate. NIH envisions a biomedical enterprise in which data and information generated in the field, laboratory, and clinic are processed and analyzed in real-time and readily shared. In an increasingly data-rich world, these advances are essential to the NIH mission of enhancing health, lengthening life, and reducing illness and disability.
Achieving this vision requires deep experience in, and knowledge of, data and computer sciences and related fields. To bring talented professionals with this necessary expertise to advance high-impact NIH programs, the ODSS created the DATA National Service Scholar Program. DATA Scholars will substantially optimize and accelerate data science in biomedicine to improve human health and well-being. The program will also encourage transformative approaches that lead to increased efficiency, innovative research, tool development, and analytics.
https://datascience.nih.gov/data-scholars-2022
|
|
NCI Support for Early-Stage Investigators
 NIH Early-Stage Investigators (ESIs) are defined as having completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and who have not previously competed successfully as Principal Investigator for a substantial NIH independent research award. Read more about NIH ESI status.
NCI is strongly committed to supporting ESIs and places special emphasis on supporting ESIs with R01 applications. This Fiscal Year 2022, NCI has an ESI R01 payline of the 16th percentile as compared to the established investigator R01 payline of the 11thpercentile. Read more about NCI FY2022 Funding Policy.
Got questions? We’ve got answers! Visit the frequently asked questions page for NIH ESIs. |
|
|
New Find Funding Wizard!
New on the NCI funding for cancer training webpage! A wizard that will help find relevant cancer training funding opportunities based on your career stage.
Check it out and tell your colleagues!
|
|
|
Apply for Extension to NIH Early-Stage Investigator Status
 Are you an NIH Early-Stage Investigator? Has your research been negatively impacted by COVID-19 or other life events? If so, you may be eligible for an extension to your NIH ESI status. Find out how to access the link for requesting an ESI extension.
If you have experienced a lapse in your research or research training or experienced periods of less than full-time effort, you are encouraged to apply for an extension to your ESI status. NIH considers ESI extension requests for COVID-19, medical concerns, disability, family care responsibilities, extended periods of clinical training, natural disasters, and active-duty military service. Extensions are determined on a case-by-case basis at the sole discretion of the NIH. Read here for instructions on how to complete and submit the NIH ESI extension request form. |
|
|
NIH Family Friendly Policies for Extramural Researchers and Trainees
 Family Friendly Policies are integral not only to ensuring we maintain a strong scientific workforce, but also a more diverse one. NIH supports various programs and policies fostering a balanced work and family life from funding available for childcare costs to extensions of ESI status. Learn more about these Family Friendly Initiatives at the NIH All About Grants podcast on NIH Family Friendly Policies. |
|
|
The Population Science Department uses the collective expertise of epidemiologists, biostatisticians, and behavioral scientists to better understand the behavioral, social, environmental, and biologic factors that affect cancer prevention, risk, survivorship, and survival. This research aims to refine personalized risk prediction and targeted intervention strategies, inform public health and clinical decision making for cancer prevention and survivorship, and reduce disparities among medically vulnerable populations. Most of the work within Population Science uses the CancerPrevention Studies (CPS), a series of large- scale prospective cohort studies built and maintained by the American Cancer Society since the 1950’s. The CPS cohorts include extensive survey-based data, other data sources such asaccelerometry, blood, stool, saliva, and tumor tissue. We are particularly interested in, but not limited to, scientists with expertise in the following areas:
- Sleep science
- Cancer Health Disparities
- Breast, endometrial, and ovarian cancer
- Gastrointestinal cancers (e.g. pancreas, colon)
- Molecular epidemiology
- Nutrition, diet patterns, or novel diet assessment
- Cancer survivorship including biologic aging
The scientists hired for these positions will initiate and direct research projects in collaboration with other intramural research scientists and the extramural scientific community that result in published peer- reviewed original research. The scientists will also serve as public spokespeople for Population Science by communicating results of their research to stakeholders-including American Cancer Society staff and volunteers, the scientific community, mainstream media, policy, and the public at large. These full-time positions offer a unique opportunity to contribute to work that has international impact.
Successful candidates should have a sustained focus on cancer epidemiology, will be expected to establish an innovative, independent research portfolio that aligns with the Society’s mission and Population Science researchpriorities, and will contribute to the scientific leadership of the CPS cohorts. Applicants must have a doctoral degree and post-doctoral training in epidemiology, behavioral science, public health, statistics/bioinformatics or a related field,as well as a consistent track-record of publication.
The positions are available immediately, and the salary is commensurate with qualifications and experience. These positions are based at the American Cancer Society’s Research Headquarters in Atlanta, GA. If you are interested, please submit a cover letter that includes a research statement and a curriculum vitae to Dr. Alpa Patel, Senior Vice President, Population Science at alpa.patel@cancer.org.
|
|
|
Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
The participating Institutes and Centers (ICs) are inviting applications to support administrative supplements to existing awards of scientists who are outstanding mentors and who have demonstrated compelling commitments and contributions to enhancing diversity, equity, inclusion, and accessibility (DEIA) in the biomedical sciences. Excellent mentorship and superior training are critical to the development of exceptional future scientists. This administrative supplement recognizes the crucial role great mentors play in the development of future leaders in the scientific research enterprise.
The supplement awards will provide up to $250,000.00 (direct costs), not to exceed the cost of the parent award, to grants supporting faculty members who have mentoring and/or mentorship as part of their existing awards and have demonstrated a commitment to outstanding mentorship and training, especially to individuals from groups identified as underrepresented in the biomedical sciences (e.g., see the Notice of NIH's of Interest in Diversity). As administrative supplements, the work proposed needs to be within the scope of the research or training that is already supported. The award must have a component related to mentoring. Examples include but are not limited to: a Research Education Program that describes mentored research experiences, a Career Development section, a Plan to Enhance Diverse Perspectives, or a discrete objective related to mentoring.
For more information, visit https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-057.html.
|
|
|
New Funding Opportunity!
We are excited to let you know that NHLBI has released two companion FOAs with the entitled of “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-015.html and “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-016.html along with the notice of availability of Frequently Asked Questions (FAQs) (https://grants.nih.gov/grants/guide/notice-files/NOT-HL-22-027.html).
|
|
Fellowship Opportunities
(NEW) NCI Post-doctoral fellowship opportunities
Cancer Research Training Award Fellowship in Health Behaviors Research
As a member of the Health Behaviors Research Branch, the fellow will work collaboratively on various projects to address cancer-related behaviors (e.g., diet and nutrition, physical activity, sleep, alcohol, medication adherence) and associated factors (e.g., genetics, family, environment, culture, policy) to advance behavioral and social science for cancer prevention and control. The program seeks candidates with a Ph.D. or equivalent degree (or highly qualified Ph.D. candidates) with a strong interest in interdisciplinary behavioral and social science research in cancer prevention and control, particularly in behavioral interventions and clinical trials, multilevel and policy research, implementation and health sciences research, and/or cross-disciplinary areas of behavioral science. See the announcement for more details.
--
Postdoctoral Fellowship in Health Equity and Basic Behavioral and Psychological Sciences Research
The Basic Biobehavioral and Psychological Sciences Branch (BBPSB) supports research fundamental to understanding human behaviors, social context, decision-making, and clinical practices associated with cancer etiology, prevention, screening, detection, diagnosis, treatment, and survivorship. Candidates trained in health equity research with a biopsychosocial background are encouraged to apply. Competitive candidates will demonstrate knowledge or interest in using their training to cultivate a health equity and cancer-relevant basic behavioral and psychological sciences research portfolio. See the announcement for more details.
|
|
Fellowship: NCI Cancer Research Training Award
The National Cancer Institute (NCI) Cancer Research Training Award is a full-time position based in Rockville, Maryland that provides opportunities for training and professional development that supports NCI Behavioral Research Program activities and contributes to the scientific literature in tobacco control and related areas of behavioral research. Start dates are January or June 2022, depending on the applicant's graduation date. Applications will be accepted until the position is filled. Please learn more here
|
|
|
Follow us on Facebook and Twitter or click to visit our GMaP R1S website.
|
|
|
|
|
We want to encourage all of our GMaP R1S members to share your research with us via the gmap email address: gmapregion1s@gmail.com, for dissemination throughout our network, so members across the region have the ability to access your recent work.
|
|
|
|
|
|
